BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 21613782)

  • 1. Angiotensin receptor blockers & endothelial dysfunction: Possible correlation & therapeutic implications.
    Radenkovic M; Stojanović M; Nešić IM; Prostran M
    Indian J Med Res; 2016 Aug; 144(2):154-168. PubMed ID: 27934794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dexmedetomidine on rats with renal ischemia-reperfusion injury and the expression of tight junction protein in kidney.
    Liu YE; Tong CC; Zhang YB; Jin HX; Gao Y; Hou MX
    Int J Clin Exp Med; 2015; 8(10):18751-7. PubMed ID: 26770491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.
    Ni H; Chen J; Pan M; Zhang M; Zhang J; Chen P; Liu B
    J Mol Histol; 2013 Dec; 44(6):693-703. PubMed ID: 23907620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms.
    Khoury NM; Marvar PJ; Gillespie CF; Wingo A; Schwartz A; Bradley B; Kramer M; Ressler KJ
    J Clin Psychiatry; 2012 Jun; 73(6):849-55. PubMed ID: 22687631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hypertensive therapy and insulin sensitivity: regulation through the microcirculation?
    Prior SJ
    Hypertens Res; 2012 Jan; 35(1):20-2. PubMed ID: 21993213
    [No Abstract]   [Full Text] [Related]  

  • 6. Endothelial Progenitor Cells at the Interface of Chronic Kidney Disease: From Biology to Therapeutic Advancement.
    Coppolino G; Cernaro V; Placida G; Leonardi G; Basile G; Bolignano D
    Curr Med Chem; 2018; 25(35):4545-4551. PubMed ID: 28933292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect.
    Yao EH; Fukuda N; Matsumoto T; Kobayashi N; Katakawa M; Yamamoto C; Tsunemi A; Suzuki R; Ueno T; Matsumoto K
    Hypertens Res; 2007 Nov; 30(11):1119-28. PubMed ID: 18250561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of benazepril on the VEGF and MVD in the remnant kidney of 5/6 subtotal nephrectomized rats].
    Yao X; Jiang YS; Lin X; Liu GX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):68-73. PubMed ID: 18245908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan protects against intermittent hypoxia-induced peritubular capillary loss by modulating the renal renin-angiotensin system and angiogenesis factors.
    Wu J; Chu Y; Jiang Z; Yu Q
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):38-48. PubMed ID: 31836883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination.
    Piecha G; Koleganova N; Gross ML; Geldyyev A; Adamczak M; Ritz E
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F137-44. PubMed ID: 18434388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction.
    Hu CH; Li ZM; DU ZM; Zhang AX; Yang DY; Wu GF
    Chin Med J (Engl); 2009 Mar; 122(5):548-55. PubMed ID: 19323906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARB treatment prevents the decrease in endothelial progenitor cells and the loss of renal microvasculature in remnant kidney.
    Yu Y; Wang Y; Zhou LN; Zheng F
    Am J Nephrol; 2011; 33(6):550-7. PubMed ID: 21613782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
    Schrijvers BF; Flyvbjerg A; De Vriese AS
    Kidney Int; 2004 Jun; 65(6):2003-17. PubMed ID: 15149314
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.